Moreover, in view of the present observations and the known role of platelets in the pathophysiology of cardiac infarction and stroke [45], CaSR activation could counteract upregulation of platelet activity by phosphate and thus reduce the risk of cardiac infarction and stroke in CKD patients [46,47]. This evidence concerns the gene CASR and stroke disorder.